Recent clinical trial results with antiplatelet therapy: Implications in stroke prevention

Cerebrovascular Diseases

Volumn 17, Issue SUPPL. 3, 2004, Pages 6-10

  Teal, Philip A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Acetylsalicylic acid; Antiplatelet therapy; Atherothrombosis; Clopidogrel; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; PLACEBO; TICLOPIDINE;

ARTERY THROMBOSIS; BLEEDING; CAROTID ARTERY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; LONG TERM CARE; PERCUTANEOUS CORONARY INTERVENTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; ST SEGMENT ELEVATION; STENT; STROKE; THROMBOCYTE ACTIVATION; TRANSIENT ISCHEMIC ATTACK; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; ASPIRIN; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; HUMANS; MYOCARDIAL INFARCTION; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; RISK REDUCTION BEHAVIOR; TICLOPIDINE;

EID: 1642578198     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000075298     Document Type: Conference Paper

References (16)

1. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P: Antithrombotic and thrombolytic therapy for ischemic stroke. Chest 2001;119:300S-320S.
2. Antithrombotic Trialists' Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
3. Schafer AI: Antiplatelet therapy. Am J Med 1996;101:199-209.
4. CAPRIE Steering Committee: A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-1339.
5. The Clopidogrel in Unstable angina to prevent Recurrent Events trial investigators: Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
6. Mehta SR, Yusuf S, Peters RJG, Bertrand ME, Lewis BS, Natarajan MK, Malmberg K, Rupprecht H-J, Zhao F, Chrolavicius S, Copland I, Fox KAA, for the Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators: Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527-533.
7. Steinhubl SR, Berger PB, Mann JT III, Fry ETA, DeLago A, Wilmer C, Topol EJ, for the CREDO Investigators: Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention. A randomized controlled trial. JAMA 2002;288:2411-2420.
8. Drouet L: Atherothrombosis as a systemic disease. Cerebrovasc Dis 2002;13(suppl 1):1-6.
9. Hankey GJ: Long-term outcome after ischaemic stroke/transient ischaemic attack. Cerebrovasc Dis 2003;16(suppl 1):14-19.
10. Guillot F: Risk of cerebrovascular and cardiac mortality after major stroke or minor/lacunar stroke: A review of community-based, follow-up studies in Europe. Cerebrovasc Dis 2003;16(suppl 4):68.
11. Yusuf S, Mehta SR, Zhao F, Gersh BJ, Commerford PJ, Blumenthal M, Budaj A, Wittlinger T, Fox KAA, on behalf of the CURE (Clopidogrel in Unstable angina to prevent Recurrent Events) Trial Investigators: Early and late effects of clopidogrel in patients with acute coronary syndromes. Circulation 2003;107:966-972.
12. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, Mautner B, Corbalan R, Radley D, Braunwald E: The TIMI Risk Score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 2000;284:835-842.
13. Budaj A, Yusuf S, Mehta S, Fox KAA, Tognoni G, Zhao F, Chrolavicius S, Hunt D, Keltai M, Grazia Franzosi M for the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Trial Investigators: Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups. Circulation 2002;106:1622-1626.
14. Peters RJG, Zao F, Lewis BS, Fox KAA, Yusuf S, on behalf of the CURE Investigators: Aspirin dose and bleeding events in the CURE study. Eur Heart J 2002;23(abstr suppl):510.
15. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ on behalf of the MATCH Investigators: Management of AThe-rothrombosis with Clopidogrel in High-risk patients with recent transient ischaemic attack or ischaemic stroke (MATCH): study design and baseline data. Cerebrovasc Dis, in press.
16. Hankey GJ: Ongoing and planned trials of antiplatelet therapy in the acute and long-term management of patients with ischaemic brain syndromes: setting a new standard of care. Cerebrovasc Dis 2004;17(suppl 3):11-16.